Congestive Heart Failure and Skin Cancer Risk: A Cross-Sectional Analysis

Introduction Congestive heart failure (CHF) is a chronic inflammatory condition that may influence immune surveillance and cancer risk. While CHF has been linked to increased incidence of certain malignancies, its relationship with skin cancer remains underexplored. Given the systemic immune changes in CHF and the immune-mediated aspects of skin cancer pathogenesis, this study aimed to assess whether CHF is associated with increased prevalence of skin cancer in a nationally representative sample of U.S. adults. Methods We analyzed data from the National Health and Nutrition Examination Survey (NHANES) collected between 2021 and 2023. CHF status was determined by self-reported physician diagnosis, and skin cancer was defined based on self-reported history of melanoma or non-melanoma skin cancer. A multivariable logistic regression model was used to assess the association between CHF and skin cancer, adjusting for age, gender, race/ethnicity, marital status, and education level. Results Among 7,791 participants, 343 (4.4%) reported a history of CHF. Skin cancer prevalence did not significantly differ between CHF and non-CHF groups. In adjusted analysis, CHF was not significantly associated with skin cancer (OR = 1.03, 95% CI: 0.64–1.63, p = 0.903). Female gender was associated with lower odds of skin cancer (OR = 0.65, p = 0.002), while college education was associated with higher odds compared to less than a 9th-grade education (OR = 3.33, p = 0.012). No other covariates showed significant associations. Conclusion Despite theoretical concerns regarding inflammation and immune dysfunction in CHF, we found no evidence that CHF is associated with increased skin cancer prevalence. Our findings suggest that systemic changes in CHF may not meaningfully impact skin cancer risk, or that detection patterns in this population may obscure true associations. The study also underscores the influence of demographic and socioeconomic factors on skin cancer reporting. Further research using prospective designs and detailed cancer subtype data is warranted to clarify potential links between CHF and skin cancer.

Authors

Institutions

Publication Details

Journal
Physician s Journal of Medicine
Published
2025-03-05
DOI
https://doi.org/10.55070/001c.134107
Primary Topic
Cutaneous Melanoma Detection and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Congestive Heart Failure and Skin Cancer Risk: A Cross-Sectional Analysis

Esther Auerbach, Marc Ganz, Shmuel Halpert, M Halabí et al.
Physician s Journal of Medicine
Cutaneous Melanoma Detection and Management
article

Congestive Heart Failure and Skin Cancer Risk: A Cross-Sectional Analysis

Esther Auerbach, Marc Ganz, Shmuel Halpert, M Halabí, Myles Goliger, Yaacov Fakiro, Gavriel Hizami
article en

Abstract

Introduction Congestive heart failure (CHF) is a chronic inflammatory condition that may influence immune surveillance and cancer risk. While CHF has been linked to increased incidence of certain malignancies, its relationship with skin cancer remains underexplored. Given the systemic immune changes in CHF and the immune-mediated aspects of skin cancer pathogenesis, this study aimed to assess whether CHF is associated with increased prevalence of skin cancer in a nationally representative sample of U.S. adults. Methods We analyzed data from the National Health and Nutrition Examination Survey (NHANES) collected between 2021 and 2023. CHF status was determined by self-reported physician diagnosis, and skin cancer was defined based on self-reported history of melanoma or non-melanoma skin cancer. A multivariable logistic regression model was used to assess the association between CHF and skin cancer, adjusting for age, gender, race/ethnicity, marital status, and education level. Results Among 7,791 participants, 343 (4.4%) reported a history of CHF. Skin cancer prevalence did not significantly differ between CHF and non-CHF groups. In adjusted analysis, CHF was not significantly associated with skin cancer (OR = 1.03, 95% CI: 0.64–1.63, p = 0.903). Female gender was associated with lower odds of skin cancer (OR = 0.65, p = 0.002), while college education was associated with higher odds compared to less than a 9th-grade education (OR = 3.33, p = 0.012). No other covariates showed significant associations. Conclusion Despite theoretical concerns regarding inflammation and immune dysfunction in CHF, we found no evidence that CHF is associated with increased skin cancer prevalence. Our findings suggest that systemic changes in CHF may not meaningfully impact skin cancer risk, or that detection patterns in this population may obscure true associations. The study also underscores the influence of demographic and socioeconomic factors on skin cancer reporting. Further research using prospective designs and detailed cancer subtype data is warranted to clarify potential links between CHF and skin cancer.

Physician s Journal of MedicineVol. 4
Technion – Israel Institute of Technology (IL), SUNY Downstate Health Sciences University (US), Touro College (US), Touro University Nevada (US)
Openalex Percentile: Top 87%
Cutaneous Melanoma Detection and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.